Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars
ABSTRACTObjectives Since the initial release of biosimilars 18 years ago, regulations for their licensing have changed considerably; however, there is no global consensus on these regulations. Establishing harmonized regulatory guidelines for the approval of biosimilars with support from the ICH, an...
Main Authors: | Sarfaraz K. Niazi, Waleed Mohammed Al-Shaqha, Zafar Mirza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Journal of Market Access & Health Policy |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/20016689.2022.2147286 |
Similar Items
-
A Proposed Global Medicines Agency (GMA) to Make Biological Drugs Accessible: Starting with the League of Arab States
by: Sarfaraz K. Niazi
Published: (2023-07-01) -
Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
by: Beverly Ingram, et al.
Published: (2021-04-01) -
Biosimilars: Harmonizing the Approval Guidelines
by: Sarfaraz K. Niazi
Published: (2022-07-01) -
A Regulatory Perspective on Biosimilar Medicines
by: Marta Agostinho Cordeiro, et al.
Published: (2024-02-01) -
Biosimilars Adoption: Recognizing and Removing the RoadBlocks
by: Niazi SK
Published: (2023-04-01)